Intravenous iron therapy
Othereach patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses
NCT Number: NCT03157050
the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.
Looking for future studies?
Notify Me19 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
each patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses
Time frame: on day 0 of start of intravenous iron and 1 week after completion of intravenous iron
change in patient health questionnaire-9 score before and after intravenous iron therapy
Benha University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06844890
Behavior, Behavioral Symptoms
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07737652
Anxiety, Anxiety Disorders
Tuscaloosa, Alabama, United States
View Trial DetailsNCT07737366
Anxiety, Anxiety Disorders
Sakarya, Turkey (Türkiye)
View Trial DetailsNCT00044174
Behavior, Behavioral Symptoms
Bethesda, Maryland, United States
View Trial Details